Eric Benevich
2016
In 2016, Eric Benevich earned a total compensation of $2.5M as Chief Commercial Officer at Neurocrine Biosciences, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $169,200 |
|---|---|
| Option Awards | $831,828 |
| Salary | $376,000 |
| Stock Awards | $1,050,908 |
| Other | $62,663 |
| Total | $2,490,599 |
Benevich received $1.1M in stock awards, accounting for 42% of the total pay in 2016.
Benevich also received $169.2K in bonus, $831.8K in option awards, $376K in salary and $62.7K in other compensation.
Rankings
In 2016, Eric Benevich's compensation ranked 3,950th out of 14,075 executives tracked by ExecPay. In other words, Benevich earned more than 71.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,950 out of 14,075 | 72nd |
Division Manufacturing | 1,379 out of 5,486 | 75th |
Major group Chemicals And Allied Products | 423 out of 1,900 | 78th |
Industry group Drugs | 308 out of 1,543 | 80th |
Industry Biological Products, Except Diagnostic Substances | 58 out of 287 | 80th |
Source: SEC filing on April 20, 2017.
Benevich's colleagues
We found five more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2016.
2016
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2016
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
2016
Christopher O'Brien
Neurocrine Biosciences
Chief Medical Officer
2016
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2016
Kyle Gano
Neurocrine Biosciences
Chief Business Development Officer
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019